» Articles » PMID: 24718946

Provision of Smoking Cessation Services in Australian Community Pharmacies: a Simulated Patient Study

Overview
Publisher Springer
Specialties Pharmacology
Pharmacy
Date 2014 Apr 11
PMID 24718946
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background: With the rising interest in expanding pharmacists' role in smoking cessation, it is pertinent that community pharmacists be equipped with up-to-date knowledge and competence to provide optimal therapeutic services that meet the demands of various presenting subsets of smokers.

Objective: To investigate and evaluate responses to requests of quitting smoking from 'high risk' smokers seeking assistance and treatment within the pharmacy venue.

Setting: Community pharmacies located within Sydney greater metropolitan area, New South Wales, Australia.

Method: A simulated patient methodology was utilised. Two scenarios were developed and enacted by two trained simulated patients in 100 randomly selected pharmacies. Scenario 1 involved a 28-year-old pregnant female who presents with a request for help in quitting smoking. Scenario 2 involved a 22-year-old female requesting a quit smoking product for her 55-year-old father who has cardiovascular problems. A standardised scoring key was designed to assess the performance of pharmacists during each encounter.

Main Outcome Measure: The primary outcome measure was the supply/non-supply of nicotine replacement products and the corresponding provision of counselling and advice to facilitate smoking cessation.

Results: A product(s) was supplied in 42 % of the 100 encounters, while a product was adequately suggested pending doctor's referral in 45 %. In 13 % of the cases, a product was not supplied based on inappropriate notions of nicotine replacement therapy not being safe in the presented scenario. Pharmacists performed better in dispensing scores (counselling about product use) as compared to pre-dispensing scores (eliciting patient history). ANOVA followed by regression analysis indicated that the estimated age and gender of the pharmacist/staff were significant predictors affecting total scores.

Conclusion: Whilst pharmacists' counselling about smoking cessation aids seems satisfactory, further education is required to improve practice standards in terms of matching a patient's history and smoking status to an appropriate product.

Citing Articles

Abstinence Rate, Adverse Events and Withdrawal Symptoms after Varenicline Use and Predicting Factors of Smoking Abstinence: A Multicentre Single-State Study in Malaysia.

Choo S, Chang C, Tangiisuran B, Latif M, Sanusi N, Harun S Int J Environ Res Public Health. 2022; 19(13).

PMID: 35805417 PMC: 9265789. DOI: 10.3390/ijerph19137757.


The Quality of Counseling for Headache OTC Medications in German Community Pharmacies Using a Simulated Patient Approach: Are There Differences between Self-Purchase and Purchase for a Third Party?.

Langer B, Kunow C ScientificWorldJournal. 2022; 2022:5851117.

PMID: 35370483 PMC: 8967581. DOI: 10.1155/2022/5851117.


Dispensing and Variabilities in Pricing of Headache OTC Medicines by Community Pharmacies in a German Big City: A Simulated Patient Approach.

Kunow C, Langer B Clinicoecon Outcomes Res. 2021; 13:843-851.

PMID: 34588789 PMC: 8476173. DOI: 10.2147/CEOR.S320728.


A Nationwide Mystery Caller Evaluation of Oral Emergency Contraception Practices from German Community Pharmacies: An Observational Study Protocol.

Kunow C, Bello M, Diedrich L, Eutin L, Sonnenberg Y, Wachtel N Healthcare (Basel). 2021; 9(8).

PMID: 34442082 PMC: 8391881. DOI: 10.3390/healthcare9080945.


Assessment of community pharmacy management towards self-medication requests of tetracyclines for pregnant women: a simulated client study in Upper Egypt.

Tawfik A, Abdelaziz A, Omran M, Rabie K, Ahmed A, Abou-Ali A Int J Clin Pharm. 2020; 43(4):969-979.

PMID: 33231814 DOI: 10.1007/s11096-020-01203-0.


References
1.
Horvat N, Koder M, Kos M . Using the simulated patient methodology to assess paracetamol-related counselling for headache. PLoS One. 2013; 7(12):e52510. PMC: 3531391. DOI: 10.1371/journal.pone.0052510. View

2.
Thomas D . [Smoking and cardiovascular diseases]. Rev Prat. 2012; 62(3):339-43. View

3.
Schneider C, Everett A, Geelhoed E, Kendall P, Murray K, Garnett P . Provision of primary care to patients with chronic cough in the community pharmacy setting. Ann Pharmacother. 2011; 45(3):402-8. DOI: 10.1345/aph.1P514. View

4.
Saengcharoen W, Lerkiatbundit S . Migraine management in community pharmacies: practice patterns and knowledge of pharmacy personnel in Thailand. Headache. 2013; 53(9):1451-63. DOI: 10.1111/head.12163. View

5.
Paul C, Walsh R, Girgis A . Nicotine replacement therapy products over the counter: real-life use in the Australian community. Aust N Z J Public Health. 2003; 27(5):491-5. DOI: 10.1111/j.1467-842x.2003.tb00820.x. View